Longeveron (LGVN) to Release Quarterly Earnings on Wednesday

Longeveron (NASDAQ:LGVN) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, August 14th. Analysts expect Longeveron to post earnings of ($1.03) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.

Longeveron (NASDAQ:LGVN) last released its quarterly earnings results on Tuesday, May 14th. The company reported ($1.61) EPS for the quarter, beating the consensus estimate of ($2.01) by $0.40. The company had revenue of $0.55 million for the quarter, compared to analyst estimates of $0.12 million. Longeveron had a negative net margin of 2,129.24% and a negative return on equity of 300.96%. During the same quarter last year, the business earned ($2.20) earnings per share. On average, analysts expect Longeveron to post $-4 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

Longeveron Stock Performance

Shares of Longeveron stock opened at $2.47 on Tuesday. The firm has a 50-day simple moving average of $2.50 and a two-hundred day simple moving average of $3.06. Longeveron has a fifty-two week low of $0.77 and a fifty-two week high of $35.60. The company has a market cap of $15.68 million, a P/E ratio of -0.26 and a beta of 0.43.

Wall Street Analyst Weigh In

Separately, HC Wainwright reduced their price target on Longeveron from $12.00 to $10.00 and set a “buy” rating for the company in a report on Monday, July 29th.

Longeveron Company Profile

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors.